Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Inappropriate Schedule of Vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a female patient who received Rota (Rotarix liquid formulation) for prophylaxis. Previously administered products included Rotarix (Patient receive 1st dose of Rotarix on 27th December 2024 with batch number 32PF3 expiry 15 May 2027). On an unknown date, the patient did not receive the 2nd dose of Rotarix liquid formulation. On an unknown date, an unknown time after receiving Rotarix liquid formulation, the patient experienced inappropriate schedule of vaccine administered (Verbatim: Inappropriate Schedule of Vaccine). The outcome of the inappropriate schedule of vaccine administered was not applicable. Additional Information: GSK receipt date: 21-MAY-2025 HCP reported about late dose of Rotarix. Patient received 1st dose on December 27, 2024 at 2 months of age and is back to received 2nd dose at 7 months of age. Also asked what was the recommendation beyond the 24 weeks for 2nd dose? It was unknown at time of reporting if patient would be receiving 2nd dose on the day of reporting. Till the time of reporting patient did not receive 2nd dose of vaccination which led to incomplete course of vaccination.